Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Christopher Gerace"'
Publikováno v:
The American Journal of Cardiology. 153:125-128
Mobile electrocardiogram (mECG) devices are being used increasingly, supplying recordings to providers and providing automatic rhythm interpretation. Given the intermittent nature of certain cardiac arrhythmias, mECGs allow instant access to a record
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2945f5fe732051d738e2731ff1cc3f06
https://doi.org/10.1016/j.amjcard.2021.05.027
https://doi.org/10.1016/j.amjcard.2021.05.027
Publikováno v:
Heart Rhythm. 18:S264
Background: Mobile electrocardiogram (mECG) devices are being used increasingly, supplying recordings to providers and providing automatic rhythm interpretation. Given the intermittent nature of certain cardiac arrhythmias, mECGs allow instant access
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a4a31d42dd7bb3fbaab41679b9165a0
https://doi.org/10.1016/j.hrthm.2021.06.657
https://doi.org/10.1016/j.hrthm.2021.06.657
Autor:
Karam Al-Issa, Ramon V. Tiu, Christopher Gerace, Eric D. Hsi, Sudipto Mukherjee, Ali Tabarroki, Bernard J. Silver, Alan E. Lichtin, Heesun J. Rogers, Valeria Visconte, Mikkael A. Sekeres
Publikováno v:
Leukemia & Lymphoma. 56:1888-1890
Sideroblastic anemia (SA) is one of the major types of anemia encountered in clinical practice. There are three primary types, namely congenital SA, acquired clonal SA and acquired reversible SA. A...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2aefcd3ea8d45bb42b38ec18602f926a
https://doi.org/10.3109/10428194.2014.976821
https://doi.org/10.3109/10428194.2014.976821
Autor:
Eric D. Hsi, Yasmine Hirbawi, Ramon V. Tiu, Ahmad Zarzour, Karam Al-Issa, Christopher Gerace, Ali Tabarroki, Jing Ai, Evan Hsi, Heesun J. Rogers, Betty K. Hamilton, Valeria Visconte
Publikováno v:
Blood. 124:3194-3194
The identification of the JAK2V617F mutation in myeloproliferative neoplasms (MPN) paved the way for the pivotal studies that led to the FDA approval of a JAK1/2 inhibitor, ruxolitinib (rux) in patients (pts) with myelofibrosis (MF). Improvement in s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5390763a33daf2edbb2403b8b8a68034
https://doi.org/10.1182/blood.v124.21.3194.3194
https://doi.org/10.1182/blood.v124.21.3194.3194
Autor:
Karam Al-Issa, Alan E. Lichtin, Ramon V. Tiu, Mikkael A. Sekeres, Eric D. Hsi, Ali Tabarroki, Valeria Visconte, Bernard J. Silver, Heesun J. Rogers, Sudipto Mukherjee, Christopher Gerace
Publikováno v:
Blood. 124:5597-5597
Background: Sideroblastic anemia (SA) can present as congenital SA (CSA), acquired clonal SA, and acquired reversible SA. Patients (pts) with SA have anemia and ring sideroblasts (RS). Acquired clonal SA is often linked to myelodysplastic syndromes (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94228a01c369305aae9c1008def0df8e
https://doi.org/10.1182/blood.v124.21.5597.5597
https://doi.org/10.1182/blood.v124.21.5597.5597